IWP
ABBV icon

IAG Wealth Partners’s AbbVie ABBV Stock Holding History

IAG Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162K Buy
746
+15
+2% +$3.33K 0.02% 132
2025
Q4 		$167K Buy
731
+3
+0.4% +$683 0.02% 126
2025
Q3 		$169K Sell
728
-421
-37% -$85.7K 0.02% 127
2025
Q2 		$213K Buy
1,149
+4
+0.3% +$743 0.03% 111
2025
Q1 		$240K Sell
1,145
-20
-2% -$3.89K 0.04% 99
2024
Q4 		$207K Sell
1,165
-104
-8% -$19.1K 0.04% 98
2024
Q3 		$251K Buy
1,269
+173
+16% +$32.3K 0.05% 90
2024
Q2 		$188K Sell
1,096
-67
-6% -$11.1K 0.04% 95
2024
Q1 		$212K Buy
1,163
+425
+58% +$73.2K 0.05% 90
2023
Q4 		$114K Sell
738
-73
-9% -$10.6K 0.03% 106
2023
Q3 		$121K Buy
811
+42
+5% +$6.17K 0.03% 98
2023
Q2 		$104K Buy
769
+3
+0.4% +$440 0.03% 113
2023
Q1 		$122K Sell
766
-33
-4% -$5.04K 0.03% 94
2022
Q4 		$129K Sell
799
-42
-5% -$6.44K 0.04% 87
2022
Q3 		$113K Buy
841
+85
+11% +$12.2K 0.04% 85
2022
Q2 		$116K Buy
756
+25
+3% +$3.82K 0.04% 83
2022
Q1 		$118K Buy
731
+41
+6% +$5.96K 0.04% 85
2021
Q4 		$93K Buy
690
+3
+0.4% +$354 0.03% 89
2021
Q3 		$75K Buy
687
+102
+17% +$11.7K 0.03% 95
2021
Q2 		$66K Buy
585
+103
+21% +$11.6K 0.02% 102
2021
Q1 		$53K Buy
482
+2
+0.4% +$214 0.02% 107
2020
Q4 		$52K Buy
480
+2
+0.4% +$192 0.02% 107
2020
Q3 		$42K Buy
478
+186
+64% +$17.5K 0.02% 110
2020
Q2 		$29K Sell
292
-9
-3% -$792 0.01% 131
2020
Q1 		$23K Buy
301
+2
+0.7% +$170 0.02% 134
2019
Q4 		$27K Buy
+299
New +$24.8K 0.02% 153

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IAG Wealth Partners's ABBV Position: Q1 2026 in Review

IAG Wealth Partners increased its AbbVie (ABBV) stake by 2.1% in Q1 2026, buying an estimated $3.33K and bringing the position to 746 shares worth $162K. The position accounts for 0.02% of the portfolio, ranked #132.

IAG Wealth Partners first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $251K in Q3 2024. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • IAG Wealth Partners held 746 shares of AbbVie worth $162K as of Q1 2026.
  • IAG Wealth Partners bought 15 AbbVie shares in Q1 2026, an estimated $3.33K.
  • AbbVie made up 0.02% of IAG Wealth Partners's portfolio in Q1 2026, its #132 holding.
  • IAG Wealth Partners first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • IAG Wealth Partners's AbbVie position peaked at $251K in Q3 2024.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on IAG Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.